Influenza: Lessons from past pandemics, warnings from current incidents

Nature Reviews Microbiology

Volumn 3, Issue 8, 2005, Pages 591-600

  Horimoto, Taisuke ^a,b   Kawaoka, Yoshihiro ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMANTADINE DERIVATIVE; ANTIVIRUS AGENT; GENE PRODUCT; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; LIVE VACCINE; OSELTAMIVIR; SIALIDASE INHIBITOR; VIRUS HEMAGGLUTININ;

AVIAN INFLUENZA; BIRD DISEASE; EPIDEMIC; ERADICATION THERAPY; HUMAN; INFLUENZA; INFLUENZA VIRUS A; NONHUMAN; POULTRY FARMING; PRIORITY JOURNAL; REVIEW; VIRAL CONTAMINATION; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; POULTRY; VIRULENCE;

AVES; AVIAN INFLUENZA VIRUS; INFLUENZA A VIRUS; INFLUENZAVIRUS A;

EID: 22944457912     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro1208     Document Type: Review

References (125)

1. Lamb, R. A. & Krug, R. M. In Fields Virology 4th edn (eds Fields, B. N., Knipe, D. M. & Howley, P. M.) Ch. 46 (Lippincott-Raven, Philadelphia, 2001).
2. Wright, P. F. & Webster, R. G. In Fields Virology 4th edn (eds Fields, B. N., Knipe, D. M. & Howley, P. M.) Ch. 47 (Lippincott-Raven, Philadelphia, 2001).
3. Fouchier, R. A. et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J. Virol. 79, 2814-2822 (2005).
4. Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M. & Kawaoka, Y. Evolution and ecology of influenza A viruses. Microbiol. Rev. 56, 152-179 (1992).
5. Johnson, N. P. & Mueller, J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bull. Hist. Med. 76, 105-115 (2002).
6. Reid, A. H. & Taubenberger, J. K. The origin of the 1918 pandemic influenza virus: a continuing enigma. J. Gen. Virol. 84, 2285-2292 (2003).
7. Simonsen, L. et al. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis. 178, 53-60 (1998).
8. Reid, A. H, Taulbenberger, J. K. & Fanning, T. G. Evidence of an absence: the genetic origins of the 1918 pandemic influenza virus. Nature Rev. Microbiol. 2, 909-914 (2004).
9. Gamblin, S. J. et al. The structure and receptor binding properties of the 1918 influenza hemagglutinin. Science 303, 1838-1842 (2004).
10. Stevens, J. et al. Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus. Science 303, 1866-1870 (2004).
11. Kobasa, D. et al. Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431, 703-707 (2004).
12. Tumpey, T. M. et al. Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. Proc. Natl Acad. Sci. USA 101, 3166-3171 (2004).
13. Kash, J. C. et al. Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. J. Virol. 78, 9499-9511 (2004).
14. Cox, N. J. & Subbarao, K. Global epidemiology of influenza: past and present. Annu. Rev. Med. 51, 407-421 (2000).
15. Scholtissek, C., Rohde, W., Von Hoyningen, V. & Rott, R. On the origin of the human influenza virus subtype H2N2 and H3N2. Virology 87, 13-20 (1978).
16. Kawaoka, T., Krauss, S. & Webster, R. G. Avian-to-human transmission of the PB1 gene of influenza A virus. J. Virol. 63, 4603-4608 (1989).
17. Zhou, N. N. et al. Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J. Virol. 73, 8851-8856 (1999).
18. Nakajima, K., Dessellberger, U. & Palese, P. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature 274, 334-339 (1978).
19. Alexander, D. J., Parsons, G. & Manvell, R. J. Experimental assessment of the pathogenicity of eight avian influenza A viruses of H5 subtype for chickens, turkeys, ducks and quail. Avian Pathol. 15, 647-662 (1986).
20. Mo, I. P., Brugh, M., Fletcher, O. J., Rowland, G. N. & Swayne, D. E. Comparative pathology of chickens experimentally inoculated with avian influenza viruses of low and high pathogenicity. Avian Dis. 41, 125-136 (1997).
21. Kobayashi, Y., Horimoto, T., Kawaoka, Y., Alexander, D. J. & Itakura, C. Pathological studies of chickens experimentally infected with two highly pathogenic avian influenza viruses. Avian Pathol. 25, 285-304 (1996).
22. White, J., Kartenbeck, J. & Helenius, A. Membrane fusion activity of influenza virus. EMBO J. 1, 217-222 (1982).
23. Klenk, H.-D., Rott, R., Orlich, M. & Blodorn, J. Activation of influenza A viruses by trypsin treatment. Virology 68, 426-439 (1975).
24. Webster, R. G. & Rott, R. Influenza virus A pathogenicity: the pivotal role of hemagglutinin. Cell 50, 665-666 (1987).
25. Gotoh, B. et al. An endoprotease homologous to the blood clotting factor X as a determinant of viral tropism in chick embryo. EMBO J. 9, 4189-4195 (1990).
26. Kido, H. et al. Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. J. Biol. Chem. 267, 13573-13579 (1992).
27. Murakami, M. et al. Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus. Eur J. Biochem. 268, 2847-2855 (2001).
28. Stieneke-Grober, A. et al. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11, 2407-2414 (1992).
29. Horimoto, T, Nakayama, K., Smeekens, S. P. & Kawaoka, Y. Proprotein-processing endoproteases PC6 and furin both activate hemagglutinin of virulent avain influenza viruses. J. Virol. 68, 6074-6078 (1994).
30. Kawaoka, Y., Naeve, C. W. & Webster, R. G. Is virulence of H5N2 influenza viruses in chicken associated with loss of carbohydrate from the hemagglutinin? Virology 139, 303-316 (1984).
31. Kawaoka, Y. & Webster, R. G. Sequence requirements for cleavage activation of influenza virus hemagglutinin expressed in mammalian cells. Proc. Natl Acad. Sci. USA 85, 324-328 (1988).
32. Horimoto, T. & Kawaoka, Y. Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus. J. Virol. 68, 3120-3128 (1994).
33. Horimoto, T et al. Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. Virology 213, 223-230 (1995).
34. Garcia, M., Crawford, J. M., Latimer, J. W., Rivera-Cruz, E. & Perdue, M. L. Heterogeneity in the haemagglutinin gene and emergence of the highly pathogenic phenotype among recent H5N2 avian influenza viruses from Mexico. J. Gen. Virol. 77, 1493-1504 (1996).
35. Banks, J. et al. Changes in the haemagglutinin and the neuraminidase genes prior to the emergence of highly pathogenic H7N1 avian influenza viruses in Italy. Arch. Virol. 146, 963-973 (2001).
36. Suarez, D. L. et al. Recombination resulting in virulence shift in avian influenza outbreak, Chile. Emerg. Infect. Dis. 10, 693-699 (2004).
37. Hirst, M. et al. Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg. Infect. Dis. 10, 2192-2195 (2004).
38. Beare, A. S. & Webster, R. G. Replication of avian influenza viruses in humans. Arch. Virol. 119, 37-42 (1991).
39. de Jong, J. C., Claas, E. C. J., Osterhaus, A. D. M. E., Webster, R. G. & Lim, W. L. A pandemic warning. Nature 389, 554 (1997).
40. Subbarao, K. et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279, 393-396 (1998).
41. Claas, E. J. et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351, 472-477 (1998).
42. Yuen, K. Y. et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351, 467-471 (1998).
43. Buxton Bridges, C. et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J. Infect. Dis. 181, 344-348 (2000).
44. Xu, X., Subbarao. K., Cox, N. J. & Guo, Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261, 15-19 (1999).
45. Cauthen, A. N., Swayne, D. E., Schultz-Cherry, S., Perdue, M. L. & Suarez, D. L. Continued circulation in China of highly pathogenic avian influenza viruses encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J. Virol. 74, 6592-6599 (2000).
46. Guan, Y. et al. Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc. Natl Acad. Sci. USA 99, 8950-8955 (2002).
47. Guan, Y. et al. H5N1 influenza: A protean pandemic threat. Proc. Natl Acad Sci. USA 101, 8156-8161 (2004).
48. Sturm-Ramirez K. M. et al. Reemerging H5N1 influenza viruses in Hong Kong in 2002 are highly pathogenic to ducks. J. Virol. 78, 4892-4901 (2004).
49. Peiris, J. S. et al. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 363, 617-619 (2004).
50. World Health Organization. Avian influenza A (H5N1). Weekly Epidemiol. Rev. 79, 65-70 (2004).
51. Li, K. S. et al. Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 430, 200-213 (2004).
52. Chen, H. et al. The evolution of H5N1 influenza viruses in ducks in southern China. Proc. Natl Acad. Sci. USA 101, 10452-10457 (2004).
53. Viseshakul, N. et al. The genome sequence analysis of H5N1 avian influenza A virus isolated from the outbreak among poultry populations in Thailand. Virology 328, 169-176 (2004).
54. ProMED-mail. Avian influenza, humans - Japan (Kyoto) (03) [online], (Archive Number 20041222. 3372, 22 Dec 2004).
55. Mase, M. et al. Characterization of H5N1 influenza A viruses isolated during the 2003-2004 influenza outbreaks in Japan. Virology 332, 167-176 (2005).
56. Lee, C. W. et al. Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea. J. Virol. 79, 3692-3702 (2005).
57. Tran, T H. et al. Avian influenza A (H5N1) in 10 patients in Vietnam. N. Engl. J. Med. 350, 1179-1188 (2004).
58. Ungchusak, K. et al. Probable person-to-person transmission of avian influenza A (H5N1). N. Engl. J. Med. 352, 333-340 (2005).
59. To, K. F. et al. Pathology of fatal human infection associated with avian influenza A H5N1 virus. J. Med. Virol. 63, 242-246 (2001).
60. Enserink, M. & Kaiser, J. Avian flu finds new mammal hosts. Science 305, 1385 (2004).
61. Kuiken, T et al. Avian H5N1 influenza in cats. Science 306, 241 (2004).
62. Nakamura, J. & Iwasa, T. On the fowl-pest infection in cat. Jpn. J. Vet. Sci. 4, 511-523 (1942).
63. Peiris, M. et al. Human infection with influenza H9N2. Lancet 354, 916-917 (1999).
64. Guo, Y. et al. Characterization of the pathogenicity of members of the newly established H9N2 influenza virus lineages in Asia. Virology 267, 279-288 (2000).
65. Lin, Y, P. et al. Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates. Proc. Natl Acad. Sci. USA 97, 9654-9658 (2000).
66. Choi, Y. K. et al. Continuing evolution of H9N2 influenza viruses in southeastern China. J. Virol. 78, 8609-8614 (2004).
67. World Health Organization disease alert: 10 December 2003. Influenza A (H9N2) in Hong Kong Special Administrative Region of China. [online], (2003).
68. Campbell, C. H., Webster, R. G. & Breese, S. S. Jr. Fowl plague virus from man. J. Int. Dis. 122, 513-516 (1970).
69. Taylor, H. R. & Turner, A. J. A case report of fowl plague keratoconjunctivitis. Br. J. Ophthalmol. 61, 86-88 (1977).
70. Webster, R. G., Goreci, J., Petursson, G. & Skirnission, K. Conjunctivitis in human beings caused by influenza A virus of seals. N. Engl. J. Med. 304, 911 (1981).
71. Kurtz, J., Menvell, R. J. & Banks, J. Avian influenza virus isolated from a woman with conjunctivitis. Lancet 348, 901-902 (1996).
72. Banks, J., Speidel, E. & Alexander, D. J. Characterization of an avian influenza A virus isolated from a human - is an intermediate host necessary for the emergence of pandemic influenza viruses? Arch. Virol. 143, 781-787 (1998).
73. Fouchier, R. A. M. et al. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proc. Natl Acad. Sci. USA 101, 1356-1361 (2004).
74. Koopmans, M. et al. Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands. Lancet 363, 587-593 (2004).
75. van Kolfschooten, F. Dutch veterinarian becomes first victim of avian influenza. Lancet 361, 1444 (2003).
76. Bosman, A. et al. Avian flu epidemic 2003: public health consequences. RIVM Report 630940004 (2004).
77. Tweed, S. A. et al. Human illness from avian influenza H7N3, British Columbia. Emerg. Infect. Dis. 10, 2196-2199 (2004).
78. Rogers, G. N. & D'Souza, B. L. Receptor binding properties of human and animal H1 influenza virus isolates. Virology 173, 317-322 (1989).
79. Connor, R. J., Kawaoka, Y., Webster, R. G. & Paulson, J. C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205, 17-23 (1994).
80. Ito, T. & Kawaoka, Y. Host-range barrier of influenza A viruses. Vet. Microbiol. 74, 71-75 (2000).
81. Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569 (2000).
82. Couceiro, J. N. S. S., Paulson, J. C. & Baum, L. G. Influenza virus strains selectively recognize sialyloligosaccharides on human respiratory epithelium: the role of the host cell in selection of hemagglutinin receptor specificity. Virus Res. 29, 155-165 (1993).
83. Ito, T. et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J. Virol. 72, 7367-7373 (1998).
84. Matrosovich, M. et al. Early alterations of the receptor-binding properties of H1, H2, and H3 avian influenza virus hemagglutinins after their introduction into mammals. J. Virol. 74, 8502-8512 (2000).
85. Matrosovich, M., Zhou, N., Kawaoka, Y. & Webster, R. G. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 73, 1146-1155 (1999).
86. Matrosovich, M. N., Matrosovich, T. Y., Gray, T., Roberts, N. A. & Klenk, H-D. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc. Natl Acad. Sci. USA 101, 4620-4624 (2004).
87. Harvey, R., Martin, A. C., Zambon, M. & Barclay, W. S. Restrictions to the adaptation of influenza A virus H5 hemagglutinin to the human host. J. Virol. 78, 502-507 (2004).
88. Matrosovich, M. N., Krauss, S. & Webster, R. G. H9N2 influenza A viruses from poultry in Asia have human virus-like receptor specificity. Virology 281, 156-162 (2001).
89. Saito, T. et al. Characterization of a human H9N2 influenza virus isolated in Hong Kong. Vaccine 20, 125-133 (2001).
90. Hatta, M., Gao, P., Halfmann, P. & Kawaoka, Y. Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 293, 1840-1842 (2001).
91. Gao, P. et al. Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong. J. Virol. 73, 3184-3189 (1999).
92. Lu, X. et al. A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans. J. Virol. 73, 5903-5911 (1999).
93. Shinya, K. et al. PB2 amino acid at position 627 affects replicative efficiency, but not cell tropism, of Hong Kong H5N1 influenza A viruses in mice. Virology 320, 258-266 (2004).
94. Clements, M. L. et al. Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers. J. Clin. Microbiol. 30, 655-662 (1992).
95. Subbarao, E. K., London, W. & Murphy, B. R. A single amino acid in the PB2 gene of influenza A virus is a determinant of host range. J. Virol. 67, 1761-1764 (1993).
96. Seo, S. H., Hoffmann, E. & Webster, R. G. Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nature Med. 8, 950-954 (2002).
97. Seo, S. H., Hoffmann, E. & Webster, R. G. The NS1 gene of H5N1 influenza viruses circumvents the host anti-viral cytokine responses. Virus Res. 103, 107-113 (2004).
98. Garcia-Sastre, A. et al. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology 252, 324-330 (1998).
99. Garcia-Sastre, A. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. Virology 279, 375-384 (2001).
100. Krug, R. M., Yuan, W., Noah, D. L. & Latham, A. G. Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein. Virology 309, 181-189 (2003).
101. Geiss, G. K. et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: the role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza. Proc. Natl Acad. Sci. USA 99, 10736-10741 (2002).
102. Cheung, C. Y. et al. Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 360, 1831-1837 (2003).
103. Deshpande, K. L., Naeve, C. W. & Webster, R. G. The neuraminidases of the virulent and avirulent A/Chicken/Pennsylvania/83 (H5N2) influenza A viruses: sequence and antigenic analyses. Virology 147, 49-60 (1985).
104. Zhou, N. N., Shortridge, K. F., Class, E. C. J., Krauss, S. L. & Webster, R. G. Rapid evolution of H5N1 influenza viruses in chickens in Hong Kong. J. Virol. 73, 3366-3374 (1999).
105. Katz, J. M. et al. Molecular correlates of influenza A H5N1 virus pathogenesis in mice. J. Virol. 74, 10807-10810 (2000).
106. Snyder, M. H., Buckler-White, A. J., London, W. T., Tierney, E. L. & Murphy, B. R. The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avian-human influenza A/Pintail/79 reassortant viruses from monkeys. J. Virol. 61, 2857-2863 (1987).
107. Wang, C., Takeuchi, K., Pinto, L. H. & Lamb, R. A. Ion channel activity of influenza A virus M2 protein: characterization of the amantadine block. J. Virol. 67, 5585-5594 (1993).
108. Crumpacker, C. In Fields Virology 4th edn (eds Fields, B. N., Knipe, D. M. & Howley, P. M.) Ch. 15 (Lippincott-Raven, Philadelphia, 2001).
109. von Itzstein, M. et al. Rational design of potent sialidase-based inhibitors of influenza virus replication. Nature 363, 418-423 (1993).
110. Gubareva, L. V., Kaiser, L. & Hayden, F. G. Influenza virus neuraminidase inhibitors. Lancet 355, 827-835 (2000).
111. Gubareva, L. V. Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors. Virus Res. 103, 199-203 (2004).
112. Kiso, M. et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet 364, 759-765 (2004).
113. Neumann, G. et al. Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl Acad. Sci. USA 96, 9345-9350 (1999).
114. Hoffmann, E., Neumann, G., Kawaoka, Y., Hobom, G., Webster, R. G. A DNA transfection system for generation of influenza A virus from eight plasmids. Proc. Natl Acad. Sci. USA 97, 6108-6113 (2000).
115. Fodor, E. et al. Rescue of influenza A virus from recombinant DNA. J. Virol. 73, 9679-9682 (1999).
116. Webby, R. J. et al. Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 363, 1099-1103 (2004).
117. Wood, J. M. & Robertson, J. S. From lethal virus to life-saving vaccine: the development of inactivated influenza vaccines for pandemic influenza. Nature Rev. Microbiol. 2, 842-847 (2004).
118. Subbarao, K. et al. Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics. Virology 305, 192-200 (2003).
119. WHO Global Influenza Programme. Production of pilot lots of inactivated influenza vaccines from reassortant derived from avian influenza viruses: interim biosafety risk assessment. [online], (2003).
120. Stephenson, I, Nicholson, K. G., Wood, J. M., Zambon, M. C. & Katz, J. M. Confronting the avian influenza threat: vaccine development for a potential pandemic. Lancet Infect. Dis. 4, 499-509 (2004).
121. Nicholson, K. G. et al. Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza. Lancet 357, 1937-1943 (2001).
122. Treanor, J. J. et al. Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans. Vaccine 19, 1732-1737 (2001).
123. Hehme, N., Engelmann, H., Kunzel, W., Neumeier, E. & Sanger, R. Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines. Med. Microbiol. Immunol. 191, 203-208 (2002).
124. Stephenson, I. et al. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. Lancet 362, 1959-1966 (2003).
125. Li, S. Q. et al. Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J. Infect. Dis. 179, 1132-1138 (1999).